Opinion|Videos|October 18, 2024
Payer and Patient Education Considerations for SCLC
Key Takeaways
- Establishing clear communication with payers and providing comprehensive clinical evidence can facilitate medication access for SCLC patients.
- Utilizing educational materials from reputable cancer organizations and support groups enhances patient understanding of SCLC.
Panelists discuss how to effectively collaborate with payers to ensure access to necessary medications for patients with small cell lung cancer (SCLC), while also exploring best practices for patient education and identifying valuable resources to share with those diagnosed with SCLC.
Advertisement
Episodes in this series
What are best practices for working with payers to ensure that patients with small cell lung cancer (SCLC) get access to the necessary medications?
How do you educate patients about SCLC, and which resources do you find useful in sharing with patients?
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly
2
Social Factors May Match, Outpace Genetic Risk in Disease Prediction
3
First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention
4
Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk
5